Common Equity: The sum of all common equity items.
Sunshine Biopharma, Inc. (SBFM) had Common Equity of $27.52M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$9.26M |
|
$-1.56M |
|
$6.84M |
|
$2.43M |
|
$10.88M |
|
$-1.61M |
|
$0.05M |
|
$-1.56M |
|
$-1.56M |
|
$-1.56M |
|
$-1.56M |
|
$-1.56M |
|
$-1.56M |
|
$-1.61M |
|
$-1.53M |
|
1.37M |
|
1.37M |
|
$-1.15 |
|
$-1.15 |
|
| Balance Sheet Financials | |
$30.67M |
|
$0.48M |
|
$2.97M |
|
$33.63M |
|
$5.62M |
|
-- |
|
$0.48M |
|
$6.09M |
|
|
Common Equity |
$27.52M |
$25.70M |
|
$27.54M |
|
2.39M |
|
| Cash Flow Statement Financials | |
$-2.99M |
|
$-0.11M |
|
$7.80M |
|
$9.12M |
|
$13.75M |
|
$4.62M |
|
$0.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.46 |
|
-- |
|
-- |
|
-- |
|
-- |
|
26.20% |
|
-17.41% |
|
-17.41% |
|
-- |
|
-16.88% |
|
-16.88% |
|
$-3.00M |
|
-- |
|
-- |
|
-- |
|
0.28 |
|
0.56 |
|
2.30 |
|
39.20 |
|
-5.68% |
|
-6.09% |
|
-4.65% |
|
-5.68% |
|
$11.53 |
|
$-2.20 |
|
$-2.19 |
|